The dates provided for baseline examinations are incorrect in the Abstract and [Tables 1](#pone-0101335-t001){ref-type="table"} and [2](#pone-0101335-t002){ref-type="table"}. The correct 5^th^ sentence of the Abstract is:

"Information on hip fracture was obtained from computerized records containing discharge diagnoses for hospitalizations between baseline examinations 1998--2000 through December 31^st^, 2009."

The authors have provided a correct version of [Table 1](#pone-0101335-t001){ref-type="table"} and [Table 2](#pone-0101335-t002){ref-type="table"} below.

10.1371/journal.pone.0092882.t001

###### Characteristics of the female study participants by baseline age group and smoking categories.

![](pone.0101335.t001){#pone-0101335-t001-1}

                                                                   *Women 46-49 years old*   *Women 71-74 years old*                                                                                                                                                            
  --------------------------------------------------------------- ------------------------- ------------------------- ----------------- ----------------- ----------------- --------- ----------------- ----------------- ----------------- ----------------- ----------------- ---------
  Number of participants                                                 1821 (100)                728 (40.0)            423 (23.2)        341 (18.7)        329 (18.1)                  1126 (100)        677 (60.1)        275 (24.4)         108 (9.6)         66 (5.9)      
  Body mass index (kg/m^2^)                                              24.8 (4.0)                25.2 (4.3)            25.1 (3.9)        24.9 (3.9)        23.6 (3.5)      \<0.001     26.2 (4.2)        26.3 (3.9)        27.1 (4.6)        25.0 (4.3)        23.0 (3.4)      \<0.001
  Total fat mass (kg)                                                    24.5 (9.7)                25.4 (10.1)           25.1 (9.7)        24.7 (9.8)        21.5 (8.2)      \<0.001     27.0 (9.6)        27.3 (9.1)        29.1 (10.4)       24.0 (9.3)        20.2 (8.0)      \<0.001
  Total lean mass (kg)                                                   40.3 (4.5)                40.5 (4.6)            40.5 (4.2)        40.5 (4.9)        39.6 (4.4)       0.006      37.6 (4.3)        37.8 (4.0)        38.0 (4.4)        37.0 (4.7)        35.1 (4.5)      \<0.001
  Fat mass (%)                                                           36.6 (7.8)                37.3 (7.8)            37.1 (7.6)        36.8 (7.6)        34.2 (7.8)      \<0.001     40.6 (8.2)        40.9 (7.7)        42.2 (8.1)        38.0 (9.1)        35.3 (8.7)      \<0.001
  Fat mass \<15%                                                           6 (0.3)                   1 (0.1)                  0                 0              5 (1.5)                     8 (0.7)           2 (0.3)           1 (0.4)           3 (2.8)           2 (3.0)      
  Fat mass \>40%                                                         577 (31.7)                263 (36.1)            138 (32.6)        108 (31.7)         68 (20.7)      \<0.001     635 (56.4)        396 (58.5)        173 (62.9)         46 (42.6)         20 (30.3)      \<0.001
  Total energy (kJ/day)                                                7947.0 (2340.0)           7827.8 (2193.7)       8042.5 (2191.4)   8140.2 (2642.8)   7879.3 (2489.6)    0.381    6575.9 (2221.1)   6561.3 (2183.5)   6573.4 (2188.9)   6625.2 (2427.0)   6666.5 (2470.3)    0.701
  No regular physical activity                                           655 (36.4)                241 (33.6)            140 (33.3)        116 (34.6)        158 (48.2)      \<0.001     443 (43.1)        273 (44.5)         94 (36.4)         51 (51.5)         25 (43.1)       0.987
  Estrogen supplementation                                               342 (25.1)                 96 (17.9)             99 (30.6)         77 (30.9)         70 (27.5)      \<0.001     125 (14.9)         72 (14.6)         29 (13.6)         15 (17.6)         9 (18.8)        0.406
  Femoral neck BMD (g/cm^2^)                                             0.96 (0.12)               0.98 (0.13)           0.96 (0.12)       0.95 (0.12)       0.93 (0.13)     \<0.001     0.76 (0.11)       0.77 (0.11)       0.77 (0.12)       0.74 (0.12)       0.73 (0.13)      0.002
  Hip fracture during follow-up[e](#nt108){ref-type="table-fn"}            4 (0.2)                   1 (0.1)               2 (0.5)             \-              1 (0.3)        0.858       100 (8.9)         51 (7.5)          22 (8.0)           9 (8.3)          18 (27.3)      \<0.001

The Hordaland Health Study^a^

Abbreviations: BMD, bone mineral density; BMI, body mass index.

Values are given as mean (standard deviation (SD)) for continuous variables and number (%) for categorical variables.

Never smoking, plasma cotinine levels \<85 nmol/L and no self-reported previous smoking; former smoking, self-reported previous smoking and plasma

cotinine levels \<85 nmol/L; moderate smoking, plasma cotinine levels between 85 and 1199 nmol/L; heavy smoking, plasma cotinine levels ≥1200 nmol/L.

Number of participants with data on femoral neck BMD, body soft tissue composition and plasma cotinine.

*P*-value for trend across smoking categories.

Hip fractures from inclusion in 1998-2000 until December 31^st^, 2009.

Total numbers may vary between variables due to varying numbers of missing data.

10.1371/journal.pone.0092882.t002

###### Characteristics of the male study participants by baseline age group and smoking categories.

![](pone.0101335.t002){#pone-0101335-t002-2}

                                                                   *Men 46-49 years old*   *Men 71-74 years old*                                                                                                                                                               
  --------------------------------------------------------------- ----------------------- ----------------------- ------------------ ------------------ ------------------ --------- ----------------- ----------------- ----------------- ----------------- ----------------- ---------
  Number of participants                                                1182 (100)              404 (34.2)            349 (29.5)         188 (15.9)         241 (20.4)                   965 (100)        245 (25.4)        555 (57.5)         87 (9.0)          78 (8.1)      
  Body mass index (kg/m^2^)                                             26.2 (3.3)              25.9 (3.2)            26.8 (3.4)         26.4 (3.3)         25.6 (3.3)       0.379      26.0 (3.1)        25.8 (3.0)        26.3 (3.0)        25.7 (3.5)        24.3 (3.3)       0.002
  Total fat mass (kg)                                                   20.6 (9.0)              19.6 (8.4)            22.5 (9.7)         20.8 (8.4)         19.4 (8.9)       0.690      21.2 (8.5)        19.9 (7.9)        22.4 (8.5)        20.4 (8.6)        17.8 (7.9)       0.202
  Total lean mass (kg)                                                  59.9 (6.2)              60.0 (6.1)            60.9 (6.2)         60.2 (6.2)         58.4 (6.0)       0.003      55.0 (5.8)        55.4 (5.7)        55.3 (5.8)        53.9 (5.5)        53.6 (6.0)       0.005
  Fat mass (%)                                                          24.7 (7.4)              23.9 (7.2)            26.1 (7.3)         24.9 (7.1)         23.9 (7.8)       0.981      27.0 (7.4)        25.7 (7.3)        28.1 (7.2)        26.6 (7.1)        23.9 (7.7)       0.315
  Fat mass \<15%                                                         107 (9.1)               43 (10.6)             19 (5.4)           14 (7.4)          31 (12.9)                    55 (5.7)          19 (7.8)          20 (3.6)           5 (5.7)          11 (14.1)     
  Fat mass \>40%                                                         31 (2.6)                 9 (2.2)              14 (4.0)           3 (1.6)            5 (2.1)         0.360       34 (3.5)           7 (2.9)          24 (4.3)           3 (3.4)              0           0.119
  Total energy (kJ/day)                                              10547.4 (2870.6)        10415.7 (2632.0)      10509.4 (2799.1)   10409.1 (2985.2)   10953.5 (3252.8)    0.073    8605.6 (2471.1)   8775.5 (2467.6)   8510.1 (2502.8)   8531.2 (2528.9)   8858.3 (2157.0)    0.878
  No regular physical activity                                          445 (38.0)              131 (32.7)            126 (36.3)         75 (40.3)          113 (47.7)      \<0.001     273 (29.3)         58 (24.3)        156 (29.2)         40 (47.6)         19 (25.3)       0.059
  Femoral neck BMD (g/cm^2^)                                            0.99 (0.13)             1.00 (0.13)          1.00 (0.14)        0.97 (0.13)        0.95 (0.12)      \<0.001     0.90 (0.14)       0.93 (0.15)       0.90 (0.14)       0.86 (0.12)       0.86 (0.14)     \<0.001
  Hip fracture during follow-up[e](#nt117){ref-type="table-fn"}           4 (0.3)                 2 (0.5)              2 (0.6)               \-                 \-           0.231       52 (5.4)          10 (4.1)          29 (5.2)           6 (6.9)           7 (9.0)        0.079

The Hordaland Health Study^a^

Abbreviations: BMD, bone mineral density; BMI, body mass index.

Values are given as mean (standard deviation (SD)) for continuous variables and number (%) for categorical variables.

Never smoking, plasma cotinine levels \<85 nmol/L and no self-reported previous smoking; former smoking, self-reported previous smoking and plasma

cotinine levels \<85 nmol/L; moderate smoking, plasma cotinine levels between 85 and 1199 nmol/L; heavy smoking, plasma cotinine levels ≥1200 nmol/L.

Number of participants with data on femoral neck BMD, body soft tissue composition and plasma cotinine.

*P*-value for trend across smoking categories.

Hip fractures from inclusion in 1998-2000 until December 31^st^, 2009.

Total numbers may vary between variables due to varying numbers of missing data.
